Who owns NeuroSense Therapeutics Ltd.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NRSN from SEC Form 13F filings across 12 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 12 institutions disclosed 397,612 shares of NeuroSense Therapeutics Ltd. worth $285,749 — about 24.4% of shares outstanding; the largest disclosed holder is UBS Group AG. Source: SEC Form 13F filings, parsed by EvidInvest.
12
13F holders
$285,749
value, 2026 filers
24.4%
of shares outstanding (397,612 sh)
2
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NRSN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | UBS Group AG | 108,636 | $78,218 | 0.0% | 6.7% | +121.3% |
| 2 | Independent Advisor Alliance | 100,000 | $72,000 | 0.0% | 6.1% | +100.0% |
| 3 | Yorkville Advisors Global, LP | 78,000 | $56,160 | 0.1% | 4.8% | 0.0% |
| 4 | COMMONWEALTH EQUITY SERVICES, LLC | 22,775 | $16,400 | 0.0% | 1.4% | 0.0% |
| 5 | PNC Financial Services Group, Inc. | 21,150 | $15,228 | 0.0% | 1.3% | 0.0% |
| 6 | Pathstone Holdings, LLC | 16,528 | $11,900 | 0.0% | 1% | 0.0% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 15,870 | $11,426 | 0.0% | 1% | 0.0% |
| 8 | XTX Topco LtdNEW | 11,473 | $8,261 | 0.0% | 0.7% | new |
| 9 | Creative Planning | 11,410 | $8,215 | 0.0% | 0.7% | -4.2% |
| 10 | HRT FINANCIAL LPNEW | 10,515 | $7,000 | 0.0% | 0.6% | new |
| 11 | JONES FINANCIAL COMPANIES LLLP | 1,000 | $757 | 0.0% | 0.1% | 0.0% |
| 12 | SBI Securities Co., Ltd. | 255 | $184 | 0.0% | 0% | -3.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.